Business Description
Shilpa Medicare Ltd
ISIN : INE790G01031
Compare
Compare
Traded in other countries / regions
530549.India IPO Date
1995-06-21Description
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 3.38 | |||||
| Interest Coverage | 1.78 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 4.77 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.3 | |||||
| 3-Year EBITDA Growth Rate | -5.2 | |||||
| 3-Year EPS without NRI Growth Rate | -32.4 | |||||
| 3-Year FCF Growth Rate | 46.8 | |||||
| 3-Year Book Growth Rate | 4.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 162.25 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 34.86 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.28 | |||||
| 9-Day RSI | 40.23 | |||||
| 14-Day RSI | 48.49 | |||||
| 6-1 Month Momentum % | 67.8 | |||||
| 12-1 Month Momentum % | 115.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.26 | |||||
| Quick Ratio | 0.77 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 294.1 | |||||
| Days Sales Outstanding | 110.21 | |||||
| Days Payable | 148.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.1 | |||||
| Shareholder Yield % | -1.28 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.16 | |||||
| Operating Margin % | 13.46 | |||||
| Net Margin % | 3.78 | |||||
| FCF Margin % | -4.16 | |||||
| ROE % | 2.5 | |||||
| ROA % | 1.49 | |||||
| ROIC % | 3.24 | |||||
| 3-Year ROIIC % | -2.55 | |||||
| ROC (Joel Greenblatt) % | 8.13 | |||||
| ROCE % | 7.36 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 161.6 | |||||
| Forward PE Ratio | 52.79 | |||||
| PE Ratio without NRI | 168.26 | |||||
| Shiller PE Ratio | 55.68 | |||||
| PS Ratio | 6.04 | |||||
| PB Ratio | 3.88 | |||||
| Price-to-Tangible-Book | 5.39 | |||||
| Price-to-Operating-Cash-Flow | 51.82 | |||||
| EV-to-EBIT | 52.11 | |||||
| EV-to-EBITDA | 31.77 | |||||
| EV-to-Forward-EBITDA | 31.21 | |||||
| EV-to-Revenue | 7.44 | |||||
| EV-to-Forward-Revenue | 6.95 | |||||
| EV-to-FCF | -178.96 | |||||
| Price-to-Median-PS-Value | 1.46 | |||||
| Price-to-Graham-Number | 7.46 | |||||
| Earnings Yield (Greenblatt) % | 1.92 | |||||
| FCF Yield % | -0.62 | |||||
| Forward Rate of Return (Yacktman) % | -6.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shilpa Medicare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 11,831.726 | ||
| EPS (TTM) (₹) | 5 | ||
| Beta | 0.7 | ||
| Volatility % | 38.26 | ||
| 14-Day RSI | 48.49 | ||
| 14-Day ATR (₹) | 40.862691 | ||
| 20-Day SMA (₹) | 844.9625 | ||
| 12-1 Month Momentum % | 115.34 | ||
| 52-Week Range (₹) | 296.45 - 959.95 | ||
| Shares Outstanding (Mil) | 97.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shilpa Medicare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shilpa Medicare Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shilpa Medicare Ltd Frequently Asked Questions
What is Shilpa Medicare Ltd(BOM:530549)'s stock price today?
The current price of BOM:530549 is ₹808.00. The 52 week high of BOM:530549 is ₹959.95 and 52 week low is ₹296.45.
When is next earnings date of Shilpa Medicare Ltd(BOM:530549)?
The next earnings date of Shilpa Medicare Ltd(BOM:530549) is .
Does Shilpa Medicare Ltd(BOM:530549) pay dividends? If so, how much?
Shilpa Medicare Ltd(BOM:530549) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers